Company page

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. is a public company traded under the ticker INO in the American market. The company has a market capitalization of approximately $91.7 million. Inovio focuses on developing innovative DNA medicines to treat various diseases.

profileINO:NASDAQAI content: aiUpdated June 24, 2026/company/inovio-pharmaceuticals-inc/c-lew0izld
Inovio Pharmaceuticals, Inc. logo
Ticker
INO:NASDAQ
Asset type
Stock
Market cap
$91.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD